These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

927 related articles for article (PubMed ID: 26373560)

  • 1. Increase of Antimyeloperoxidase Antineutrophil Cytoplasmic Antibody (ANCA) in Patients with Renal ANCA-associated Vasculitis: Association with Risk to Relapse.
    Yamaguchi M; Ando M; Kato S; Katsuno T; Kato N; Kosugi T; Sato W; Tsuboi N; Yasuda Y; Mizuno M; Ito Y; Matsuo S; Maruyama S
    J Rheumatol; 2015 Oct; 42(10):1853-60. PubMed ID: 26373560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Between Reappearance of Myeloperoxidase-Antineutrophil Cytoplasmic Antibody and Relapse in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Subgroup Analysis of Nationwide Prospective Cohort Studies.
    Watanabe H; Sada KE; Matsumoto Y; Harigai M; Amano K; Dobashi H; Fujimoto S; Usui J; Yamagata K; Atsumi T; Banno S; Sugihara T; Arimura Y; Matsuo S; Makino H;
    Arthritis Rheumatol; 2018 Oct; 70(10):1626-1633. PubMed ID: 29790303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seasonal Influence on the Risk of Relapse at a Rise of Antineutrophil Cytoplasmic Antibodies in Vasculitis Patients with Renal Involvement.
    Kemna MJ; Cohen Tervaert JW; Broen K; Timmermans SAMEG; van Paassen P; Damoiseaux JGMC
    J Rheumatol; 2017 Apr; 44(4):473-481. PubMed ID: 28202741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical presentation and outcome prediction of clinical, serological, and histopathological classification schemes in ANCA-associated vasculitis with renal involvement.
    Córdova-Sánchez BM; Mejía-Vilet JM; Morales-Buenrostro LE; Loyola-Rodríguez G; Uribe-Uribe NO; Correa-Rotter R
    Clin Rheumatol; 2016 Jul; 35(7):1805-16. PubMed ID: 26852317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of severe renal disease in ANCA positive and negative small vessel vasculitis with rituximab.
    Shah S; Hruskova Z; Segelmark M; Morgan MD; Hogan J; Lee SK; Dale J; Harper L; Tesar V; Jayne DR; Geetha D
    Am J Nephrol; 2015; 41(4-5):296-301. PubMed ID: 26044574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics and Outcomes of Granulomatosis With Polyangiitis (Wegener) and Microscopic Polyangiitis Requiring Renal Replacement Therapy: Results From the European Renal Association-European Dialysis and Transplant Association Registry.
    Hruskova Z; Stel VS; Jayne D; Aasarød K; De Meester J; Ekstrand A; Eller K; Heaf JG; Hoitsma A; Martos Jimenéz C; Ravani P; Wanner C; Tesar V; Jager KJ
    Am J Kidney Dis; 2015 Oct; 66(4):613-20. PubMed ID: 25975963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between sinusitis and relapse and changes in the myeloperoxidase-antineutrophil cytoplasmic antibody in microscopic polyangiitis.
    Tanaka H; Yamaguchi M; Katsuno T; Sugiyama H; Iwagaitsu S; Nobata H; Kinashi H; Banno S; Ishimoto T; Ito Y
    PLoS One; 2020; 15(12):e0243572. PubMed ID: 33301468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term efficacy of remission-maintenance regimens for ANCA-associated vasculitides.
    Terrier B; Pagnoux C; Perrodeau É; Karras A; Khouatra C; Aumaître O; Cohen P; Decaux O; Desmurs-Clavel H; Maurier F; Gobert P; Quémeneur T; Blanchard-Delaunay C; Bonnotte B; Carron PL; Daugas E; Ducret M; Godmer P; Hamidou M; Lidove O; Limal N; Puéchal X; Mouthon L; Ravaud P; Guillevin L;
    Ann Rheum Dis; 2018 Aug; 77(8):1150-1156. PubMed ID: 29724729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antineutrophil cytoplasmic antibody negative pauci-immune extracapillary glomerulonephritis.
    Villacorta J; Diaz-Crespo F; Acevedo M; Guerrero C; Mollejo M; Fernandez-Juarez G
    Nephrology (Carlton); 2016 Apr; 21(4):301-7. PubMed ID: 26369898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of antineutrophil cytoplasmic antibodies in small-vessel vasculitis.
    Lurati-Ruiz F; Spertini F
    J Rheumatol; 2005 Nov; 32(11):2167-72. PubMed ID: 16265696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five factor score of more than 1 is associated with relapse during the first 2 year-follow up in patients with eosinophilic granulomatosis with polyangiitis.
    Kim DS; Song JJ; Park YB; Lee SW
    Int J Rheum Dis; 2017 Sep; 20(9):1261-1268. PubMed ID: 28261989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in proteinase 3 anti-neutrophil cytoplasm autoantibody levels in early systemic granulomatosis with polyangiitis (Wegener's) may reflect treatment rather than disease activity.
    Rasmussen N; Salmela A; Ekstrand A; de Groot K; Gregorini G; Cohen Tervaert JW; Gross WL; Wiik A; Jayne DR;
    Clin Exp Rheumatol; 2013; 31(1 Suppl 75):S38-44. PubMed ID: 23380137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors Determining the Clinical Utility of Serial Measurements of Antineutrophil Cytoplasmic Antibodies Targeting Proteinase 3.
    Fussner LA; Hummel AM; Schroeder DR; Silva F; Cartin-Ceba R; Snyder MR; Hoffman GS; Kallenberg CG; Langford CA; Merkel PA; Monach PA; Seo P; Spiera RF; William St Clair E; Tchao NK; Stone JH; Specks U;
    Arthritis Rheumatol; 2016 Jul; 68(7):1700-10. PubMed ID: 26882078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiproteinase 3 antineutrophil cytoplasmic antibodies and disease activity in Wegener granulomatosis.
    Finkielman JD; Merkel PA; Schroeder D; Hoffman GS; Spiera R; St Clair EW; Davis JC; McCune WJ; Lears AK; Ytterberg SR; Hummel AM; Viss MA; Peikert T; Stone JH; Specks U;
    Ann Intern Med; 2007 Nov; 147(9):611-9. PubMed ID: 17975183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long term azathioprine maintenance therapy in ANCA-associated vasculitis: combined results of long-term follow-up data.
    de Joode AAE; Sanders JSF; Puéchal X; Guillevin LP; Hiemstra TF; Flossmann O; Rasmussen N; Westman K; Jayne DR; Stegeman CA
    Rheumatology (Oxford); 2017 Nov; 56(11):1894-1901. PubMed ID: 28977502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A retrospective study on the outcomes of MPO-ANCA-associated vasculitis in dialysis-dependent patients.
    Hasegawa M; Hattori K; Sugiyama S; Asada H; Yamashita H; Takahashi K; Hayashi H; Koide S; Sato W; Yuzawa Y
    Mod Rheumatol; 2016; 26(1):110-4. PubMed ID: 25967129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double Filtration Plasmapheresis in the Treatment of Antineutrophil Cytoplasmic Autoantibody Associated Vasculitis With Severe Renal Failure: A Preliminary Study of 15 Patients.
    Chen Y; Yang L; Li K; Liu Z; Gong D; Zhang H; Liu Z; Hu W
    Ther Apher Dial; 2016 Apr; 20(2):183-8. PubMed ID: 26948291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of treatment resistance and relapse in Chinese patients with antineutrophil cytoplasmic antibody-associated disease.
    Cao Y; Tian Z; Li W; Ma L; Yu Y; Ren W
    J Rheumatol; 2014 May; 41(5):916-22. PubMed ID: 24634200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis.
    Hogan SL; Falk RJ; Chin H; Cai J; Jennette CE; Jennette JC; Nachman PH
    Ann Intern Med; 2005 Nov; 143(9):621-31. PubMed ID: 16263884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term Prognosis of Anti-Neutrophil Cytoplasmic Antibody-Negative Renal Vasculitis: Cohort Study in Korea.
    Lee SW; Yu MY; Baek SH; Ahn SY; Kim S; Na KY; Chae DW; Chin HJ
    J Korean Med Sci; 2016 Apr; 31(4):542-6. PubMed ID: 27051237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.